chr19-53992927-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145814.2(CACNG6):c.50C>T(p.Ala17Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145814.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CACNG6 | NM_145814.2 | c.50C>T | p.Ala17Val | missense_variant | 1/4 | ENST00000252729.7 | |
CACNG6 | NM_145815.2 | c.50C>T | p.Ala17Val | missense_variant | 1/3 | ||
CACNG6 | NM_031897.3 | c.50C>T | p.Ala17Val | missense_variant | 1/2 | ||
CACNG6 | NR_102308.2 | n.49+1730C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CACNG6 | ENST00000252729.7 | c.50C>T | p.Ala17Val | missense_variant | 1/4 | 1 | NM_145814.2 | P1 | |
CACNG6 | ENST00000346968.2 | c.50C>T | p.Ala17Val | missense_variant | 1/3 | 5 | |||
CACNG6 | ENST00000352529.1 | c.50C>T | p.Ala17Val | missense_variant | 1/2 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1245854Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 607714
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 11, 2023 | The c.50C>T (p.A17V) alteration is located in exon 1 (coding exon 1) of the CACNG6 gene. This alteration results from a C to T substitution at nucleotide position 50, causing the alanine (A) at amino acid position 17 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.